Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ)
CNY 4.16
(3.48%)
CNY 4.16
(3.48%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.74 Billion CNY | 20.51% |
| 2022 | 1.44 Billion CNY | 0.09% |
| 2021 | 1.44 Billion CNY | 7.6% |
| 2020 | 1.34 Billion CNY | -10.8% |
| 2019 | 1.5 Billion CNY | 1.56% |
| 2018 | 1.48 Billion CNY | -19.95% |
| 2017 | 1.85 Billion CNY | 27.04% |
| 2016 | 1.45 Billion CNY | 44.17% |
| 2015 | 1.01 Billion CNY | -19.3% |
| 2014 | 1.25 Billion CNY | -8.75% |
| 2013 | 1.37 Billion CNY | 8.16% |
| 2012 | 1.26 Billion CNY | 10.96% |
| 2011 | 1.14 Billion CNY | 25.07% |
| 2010 | 914.1 Million CNY | 45.66% |
| 2009 | 627.54 Million CNY | -30.89% |
| 2008 | 908.08 Million CNY | 64.93% |
| 2007 | 550.59 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 570.39 Million CNY | 23.25% |
| 2024 Q1 | 378.1 Million CNY | -61.36% |
| 2024 Q2 | 468.63 Million CNY | 23.94% |
| 2023 Q1 | 381.71 Million CNY | 7.82% |
| 2023 Q2 | 144.81 Million CNY | -62.06% |
| 2023 Q4 | 978.61 Million CNY | 313.8% |
| 2023 FY | 1.74 Billion CNY | 20.51% |
| 2023 Q3 | 236.49 Million CNY | 63.31% |
| 2022 Q4 | 354.01 Million CNY | -0.05% |
| 2022 Q2 | 445.25 Million CNY | 1.44% |
| 2022 Q1 | 438.93 Million CNY | 22.52% |
| 2022 Q3 | 354.2 Million CNY | -20.45% |
| 2022 FY | 1.44 Billion CNY | 0.09% |
| 2021 Q2 | 306.63 Million CNY | -8.11% |
| 2021 FY | 1.44 Billion CNY | 7.6% |
| 2021 Q3 | 445.34 Million CNY | 45.24% |
| 2021 Q4 | 358.26 Million CNY | -19.55% |
| 2021 Q1 | 333.68 Million CNY | 26.72% |
| 2020 Q1 | 237.86 Million CNY | -25.6% |
| 2020 Q4 | 263.32 Million CNY | -47.36% |
| 2020 Q3 | 500.26 Million CNY | 46.91% |
| 2020 FY | 1.34 Billion CNY | -10.8% |
| 2020 Q2 | 340.51 Million CNY | 43.16% |
| 2019 Q3 | 396.51 Million CNY | -6.39% |
| 2019 Q1 | 364.62 Million CNY | 9.28% |
| 2019 FY | 1.5 Billion CNY | 1.56% |
| 2019 Q4 | 319.7 Million CNY | -19.37% |
| 2019 Q2 | 423.59 Million CNY | 16.17% |
| 2018 Q1 | 450.74 Million CNY | -17.85% |
| 2018 FY | 1.48 Billion CNY | -19.95% |
| 2018 Q4 | 333.67 Million CNY | 45.49% |
| 2018 Q3 | 229.34 Million CNY | -50.96% |
| 2018 Q2 | 467.63 Million CNY | 3.75% |
| 2017 Q2 | 465.58 Million CNY | 20.66% |
| 2017 Q1 | 385.87 Million CNY | -10.87% |
| 2017 FY | 1.85 Billion CNY | 27.04% |
| 2017 Q4 | 548.67 Million CNY | 21.79% |
| 2017 Q3 | 450.49 Million CNY | -3.24% |
| 2016 FY | 1.45 Billion CNY | 44.17% |
| 2016 Q2 | 344.46 Million CNY | 2.68% |
| 2016 Q4 | 432.96 Million CNY | 25.94% |
| 2016 Q3 | 343.79 Million CNY | -0.2% |
| 2016 Q1 | 335.46 Million CNY | 39.93% |
| 2015 Q2 | 267.11 Million CNY | -13.29% |
| 2015 Q1 | 308.06 Million CNY | 4.06% |
| 2015 FY | 1.01 Billion CNY | -19.3% |
| 2015 Q4 | 239.74 Million CNY | 22.63% |
| 2015 Q3 | 195.49 Million CNY | -26.81% |
| 2014 Q4 | 296.06 Million CNY | 8.62% |
| 2014 FY | 1.25 Billion CNY | -8.75% |
| 2014 Q3 | 272.55 Million CNY | -27.54% |
| 2014 Q2 | 376.15 Million CNY | 22.41% |
| 2014 Q1 | 307.28 Million CNY | -4.17% |
| 2013 Q4 | 320.65 Million CNY | 0.84% |
| 2013 Q1 | 334.54 Million CNY | -2.95% |
| 2013 Q2 | 398.89 Million CNY | 19.24% |
| 2013 FY | 1.37 Billion CNY | 8.16% |
| 2013 Q3 | 317.98 Million CNY | -20.29% |
| 2012 Q4 | 344.7 Million CNY | 16.24% |
| 2012 Q1 | 304.44 Million CNY | 43.64% |
| 2012 Q3 | 296.53 Million CNY | -8.15% |
| 2012 Q2 | 322.86 Million CNY | 6.05% |
| 2012 FY | 1.26 Billion CNY | 10.96% |
| 2011 Q4 | 211.94 Million CNY | -37.75% |
| 2011 Q3 | 340.47 Million CNY | 0.67% |
| 2011 Q2 | 338.19 Million CNY | 33.86% |
| 2011 Q1 | 252.65 Million CNY | 1.88% |
| 2011 FY | 1.14 Billion CNY | 25.07% |
| 2010 Q1 | 183.23 Million CNY | 32.09% |
| 2010 Q3 | 232.64 Million CNY | -7.03% |
| 2010 FY | 914.1 Million CNY | 45.66% |
| 2010 Q4 | 247.99 Million CNY | 6.6% |
| 2010 Q2 | 250.22 Million CNY | 36.56% |
| 2009 Q3 | 151.74 Million CNY | 0.0% |
| 2009 Q4 | 138.71 Million CNY | -8.59% |
| 2009 FY | 627.54 Million CNY | -30.89% |
| 2008 FY | 908.08 Million CNY | 64.93% |
| 2007 FY | 550.59 Million CNY | 0.0% |